A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Teva Branded Pharmaceutical Products R&D, Inc.
Age
13–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The participant has a documented diagnosis of asthma
The participant is currently on treatment with an inhaled corticosteroid (ICS) with a long-acting beta2 antagonist (LABA).
The participant is currently using inhaled albuterol sulfate as rescue medication and is willing to discontinue all other rescue medications and replace them with the study provided Albuterol eMDPI.
The participant can read and communicate in English and is familiar with and is willing to use his/her own smart device and download and use the App.
* Additional criteria apply, please contact the investigator for more information
You may not be if
The participant has any clinically significant uncontrolled medical condition (treated or untreated) other than asthma.
The participant was hospitalized for severe asthma in the last 30 days.
The participant has a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap (ACO).
The participant is a current smoker or has a greater than 10 pack-year history of smoking.
The participant is currently being treated with systemic corticosteroids (oral, intramuscular, or intravenous) or has been treated within the last 30 days.
The participant has any treatment with biologics for asthma (for example, omalizumab, anti-IL5, anti-IL5R, anti-IL4R), or has had such treatment within the last 90 days.
* Additional criteria apply, please contact the investigator for more information
Clareo Health | A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
